These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 27528038)
1. Immunohistochemical Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Hyperplasia, Neoplasia and Supporting Stroma. Levi M; Brunetti B; Sarli G; Benazzi C J Comp Pathol; 2016 Nov; 155(4):277-285. PubMed ID: 27528038 [TBL] [Abstract][Full Text] [Related]
2. P-Glycoprotein and Breast Cancer Resistance Protein in Canine Inflammatory and Noninflammatory Grade III Mammary Carcinomas. Levi M; Peña L; Alonso-Díez A; Brunetti B; Muscatello LV; Benazzi C; Pérez-Alenza MD; Sarli G Vet Pathol; 2019 Nov; 56(6):840-847. PubMed ID: 31526115 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours. Petterino C; Rossetti E; Bertoncello D; Martini M; Zappulli V; Bargelloni L; Castagnaro M J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):174-8. PubMed ID: 16629950 [TBL] [Abstract][Full Text] [Related]
4. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells. Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours. Rabanal RM; Else RW Res Vet Sci; 1994 Mar; 56(2):225-33. PubMed ID: 7514803 [TBL] [Abstract][Full Text] [Related]
6. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours. Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337 [TBL] [Abstract][Full Text] [Related]
7. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer. Kovalev AA; Tsvetaeva DA; Grudinskaja TV Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439 [TBL] [Abstract][Full Text] [Related]
8. Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum. Tucker TG; Milne AM; Fournel-Gigleux S; Fenner KS; Coughtrie MW Biochem Pharmacol; 2012 Jan; 83(2):279-85. PubMed ID: 22062654 [TBL] [Abstract][Full Text] [Related]
9. Myoepithelial cell layer integrity in canine mammary carcinoma. Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585 [TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 in canine mammary tumours. Paltian V; Alldinger S; Baumgärtner W; Wohlsein P J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009 [TBL] [Abstract][Full Text] [Related]
11. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia. Saad ES; Milley KM; Al-Khan AA; Nimmo JS; Bacci B; Tayebi M; Day MJ; Richardson SJ; Danks JA J Comp Pathol; 2017 May; 156(4):352-365. PubMed ID: 28449818 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of p63 protein and calponin in canine mammary tumours. Łopuszyński W; Szczubiał M; Millán Y; Guil-Luna S; Sánchez-Céspedes R; Martin de Las Mulas J; Śmiech A; Bulak K Res Vet Sci; 2019 Apr; 123():232-238. PubMed ID: 30685648 [TBL] [Abstract][Full Text] [Related]
13. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland. Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients. Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504 [TBL] [Abstract][Full Text] [Related]
15. Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer. Kim YH; Ishii G; Goto K; Ota S; Kubota K; Murata Y; Mishima M; Saijo N; Nishiwaki Y; Ochiai A Lung Cancer; 2009 Jul; 65(1):105-11. PubMed ID: 19036469 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques. Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006 [TBL] [Abstract][Full Text] [Related]
17. Expression of Breast Cancer Resistance Protein (BCRP-1) in canine mammary adenocarcinomas and adenomas. Nowak M; Madej JA; Dziegiel P In Vivo; 2009; 23(5):705-9. PubMed ID: 19779104 [TBL] [Abstract][Full Text] [Related]
18. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues. Faustino AM; van Garderen E; Schalken JA; Nederbragt H J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316 [TBL] [Abstract][Full Text] [Related]
19. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892 [TBL] [Abstract][Full Text] [Related]
20. Expression of Oxytocin Receptors in Canine Mammary Tumours. Benavente MA; Bianchi CP; Aba MA J Comp Pathol; 2019 Jul; 170():26-33. PubMed ID: 31375156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]